Dr.david Horn Solomon
Board of director
pharmaceutical
TX CELL
France
Biography
Dr. David Horn Solomon studied medicine and immunology at Cornell Medical College and the Sloan Kettering Cancer Center in New York where he received his doctorate in 1991. He has served as a faculty member at Columbia University’s College of Physicians and Surgeons. From 2003 to 2006, David headed healthcare investing at Carrot Capital Healthcare Ventures in New York. He has held leadership positions at several biotechnology, pharmaceutical and medical device companies, including Remedy Pharmaceuticals, Critical Diagnostics and Vital Sensors. David has extensive experience as a CEO in listed biotech companies, healthcare investing and pharmacology research. David was CEO of Zealand Pharma A/S (Nasdaq CO: ZEAL) from 2008 to 2015. David is currently on the boards of Onxeo in Paris (NYSE and NASDAQ) and Promosome, in La Jolla, CA.
Research Interest
Mainly focused in designing Remedy Pharmaceuticals, Critical Diagnostics and Vital Sensors.
